1143 - Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Yueh-Ming Loo, PhD (she/her/hers)

Director, Virology and Vaccine Discovery
AstraZeneca
Gaithersburg, Maryland, United States

Co-Author(s)

AH

Andrew S. Herbert, PhD

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
AK

Ana I. Kuehne, PhD

United States Army Medical Research Institute of Infectious Disease
Fort Detrick, Maryland, United States
PM

Patrick M. McTamney, PhD

AstraZeneca
Gaithersburg, Maryland, United States
RR

Richard Roque, B.S.

AstraZeneca
Gaithersburg, Maryland, United States
AM

Alicia M. Moreau, DVM, DACVP

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
RB

Russell Bakken, None

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
CS

Christopher P. Stefan, PhD

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
JK

Jeffrey W. Koehler, PhD

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
KD

Korey L. Delp, B.S., Biology

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
SC

Susan R. Coyne, B.S., Biochemistry

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
CK

Christopher D. Kane, PhD

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
JD

John M. Dye, PhD

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, Maryland, United States
YC

Yingyun Cai, PhD

AstraZeneca
Gaithersburg, Maryland, United States
ME

Mark T. Esser, PhD

Phylogenetic and alpha toxin variant analyses of Staphylococcus aureus strains isolated from patient
AstraZeneca
Gaithersburg, Maryland, United States